analysis…) The study further said India spends just 1 per cent of its GDP on R&D, while countries like Israel spends 4.2 per cent, Japan 3.7 per cent, US 2.7 per cent and China 2.0 per cent. A sector-wise analysis shows that pharma, biotech and computer technology industries are leading contributors to IP creation in the country. Pharmaceutical and biotech companies alone contribute 30 per cent of the patents filed from India (20072012). In addition, several MNC R&D centres in India are leveraging
Words: 815 - Pages: 4
Jointly Managed by Srividhya Rajesh and S Bharath Sundaram Balanced Fund CRISIL Balanced Fund Index S&P CNX Nifty Index Jointly Managed by Srividhya Rajesh and J Venkatesan Sundaram Tax Saver BSE 200 Index S&P CNX Nifty Index S Bharath Sundaram Global Advantage Fund MSCI Index CNX Nifty 30/06/11 30/06/10 30/06/09 30/06/12 (%) 30/06/11 (%) 30/06/10 (%) Last 3 years (%) Last 5 years (%) Since Inception Last 8 years (%) Returns (%) ` 10,000 -6.8 -10.2 -6.5 7.8 -4.1
Words: 28451 - Pages: 114
Department of Technology Management and Innovation MG 7953 Global Innovation Fall 2014 Professor: Tom Helling Saturday @ 1:30-6:00 pm (see dates of class per session dates below) Contact Details: th930@nyu.edu 917-593-0946 (mobile) Course Description: This course focuses on the global dimension of technology-enabled innovation. Topics covered include: motivation for a global business outlook, how to proactively access global sources of innovation, coordination and organization of innovation-oriented
Words: 1966 - Pages: 8
Corporate Social Responsibility is the continuing commitment by business to behave ethically and contribute to economic development while improving the quality of life of the workforce and their families as well as of the local community and society. There are four Corporate Social Responsibilities: * Economic Responsibility * Legal Responsibility * Ethical Responsibility * Discretionary responsibility Objective of the Report The objective of the term paper is to highlight the
Words: 2478 - Pages: 10
Terrm Paper Performance dynamics of an industry enterprise in Bangladesh. A case study of Square Pharmaceuticals Ltd. By Nisith Kumar Mondal ID no.- 10415004 MBA Program, Summer-2011 School of Business University of Information Technology and Sciences Baridhara Campus Dhaka-Bangladesh 2011 Historical Background |ABOUT US |
Words: 3118 - Pages: 13
Reddy’s Laboratories-Growing pain This case study is about Dr Reddy's Laboratories Ltd (DRL), a global pharmaceutical company. Established in 1984, DRL was the largest Indian pharmaceutical company with a net worth of Rs.58 billion in 2007. As a fully integrated pharmaceutical company, DRL provided affordable medicines through its three core businesses - Pharmaceutical Services and Active Ingredients, Global Generics, and Proprietary Products. Since 2008, however, the drug maker went through a very difficult
Words: 1901 - Pages: 8
to IT and Telecommunications (IT & Tel)* o Introduction to Infrastructure (Infra. Mgt.)* o Industrial Pharmacy and Pharmaceutical Technology (Pharma. Mgt.)* o Hospital Planning and Organization (Hosp. Mgt.)* MBA-122 *R. Mgt= Retail Management; B&I= Banking & Insurance; IT & Tel.= IT & Telecommunication; Infra. Mgt.=Infrastructural Management; Pharma. Mgt.=Pharmaceutical Management; Hosp. Mgt.=Hospital Management. TRIMESTER – III CODE MBA-133 MBA-143 MBA-153 MBA-163a MBA-163b PAPER Legal
Words: 30662 - Pages: 123
products In this report, efforts have been made to analyze Acme’s strategy to maintain its leading position in the market and the difficulties it is facing while operating in the industry. This report starts with a company background and then proceeds with an analysis of the external and internal environment of the industry and the company, followed by its strategic practices at different levels, understanding the company mission, vision and objectives; it’s financial and marketing performance and
Words: 12114 - Pages: 49
relative advantages and disadvantages. Use examples from any relevant sector, not just "Big Pharma". Summary The paper presents a contrast between conservative and aggressive growth options. It discusses mergers and acquisitions, organic growth and alliances using examples from a range of industries which include online businesses, brewery firms, soft drink giants and also a major pharmaceutical industry merger. In examining the interface between the different growth options the paper posits that
Words: 928 - Pages: 4
an undercover agent with the Drug Enforcement Administration and the Food and Drug Administration, Aaron Graham saw firsthand how counterfeit drugs can slip into the pharmaceutical supply chain. Graham, now VP and chief security officer for Purdue Pharma, once posed as the manager of an "institutional pharmacy" selling drugs at a discount to secondary wholesalers who were then supposed to sell them to nursing homes. Soon after he began, his phone started ringing. Dozens of smaller pharmaceutical wholesale
Words: 3359 - Pages: 14
